Cost and patency rate targets for the development of endovascular devices to treat femoropopliteal arterial disease

Radiology

Volumn 218, Issue 2, 2001, Pages 464-469

  Muradin, G S R ^a   Hunink, M G M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Arteries, extremities; Arteries, grafts and prostheses; Arteriosclerosis; Cost effectiveness; Interventional procedures, comparative studies; Technology assessment

Indexed keywords

ARTERY GRAFT; ARTICLE; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; INTERVENTIONAL RADIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR;

EID: 0035146013     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.218.2.r01ja09464     Document Type: Article

References (30)

1. Management of peripheral arterial disease (PAD): TASC Working Group
2. Efficacy of balloon angioplasty of the superficial femoral artery and popliteal artery in the relief of leg ischemia
3. Angioplasty gives good results in critical lower limb ischaemia: A 5-year follow-up in patients with known ankle pressure and diabetic status having femoropopliteal dilations
4. Patency results of percutaneous and surgical revascularization for femoropopliteal arterial disease
5. Cost-identification analysis of revascularization procedures on patients with peripheral arterial occlusive disease
6. Balloon angloplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: A comparative randomized study
7. A comparison study of self-expandable stents vs balloon angioplasty alone in femoropopliteal artery occlusions
8. Focusing technology assessment using medical decision theory
9. Noninvasive imaging for the diagnosis of coronary artery disease: Focusing the development of new diagnostic technology
10. Revascularization for femoropopliteal disease: A decision and cost-effectiveness analysis
11. Hospital costs of revascularization procedures for femoropopliteal arterial disease
12. Relationship of severity of lower limb peripheral vascular disease to mortality and morbidityy: A six-year follow-up study
13. Basic data related to the natural history of intermittent claudication
14. The early results of vascular surgery in patients 75 years of age and older: An analysis of 3259 cases
15. Transmetatarsal amputation: The role of adjunctive revascularization
16. Outcomes of lower extremity amputations
17. The costs of surgery for limb-threatening ischaemia
18. Cost of treating advanced leg ischemia
19. Cost factors in limb-threatening ischaemia due to infrainguinal arteriosclerosis
20. The economics of femorocrural reconstruction for critical leg ischemia with and without autologous vein
21. Costs and benefits of prosthetic vascular surgery
22. Medical costs of coronary artery disease in the United States
23. Mortality over a period of 10 years in patients with peripheral arterial disease
24. Time preference
25. Net health benefitS: A new framework for the analysis of uncertainty in cost-effectiveness analysis
26. Reporting cost-effectiveness studies and results
27. Balloon-expandable endobypass for femoropopliteal atherosclerotic occlusive disease: A preliminary evaluation of fifty-five patients
28. Occlusive and aneurysmal peripheral arterial disease: Assessment of a stent-graff system
29. Long-term follow-up of endoluminal grafting for aneurysmal and occlusive disease in the superficial femoral artery
30. Endovascular stent-grafts for superficial femoral artery disease: Results of 1-year follow-up